Welcome to the new Independent website. We hope you enjoy it and we value your feedback. Please contact us here.


Glaxo pledges to invest £500m in UK after 'patent box' reforms

GlaxoSmithKline plans to invest more than £500m in manufacturing projects in the UK after the Chancellor, George Osborne, backed the previous government's plans for a lower 10 per cent corporate tax rate on profits from newly commercialised patents.

David Prosser: Two measures that raise doubts about Coalition's

Outlook There was something of a love-in at the Confederation of British Industry (CBI) conference, with a bevy of ministers down to say how much they loved business and some sweeties to share in the form of big speeches and big announcements. No wonder. Business leaders are being courted because they are desperately needed to help to fill the gap created by George Osborne's 500,000 job cuts.

Glaxo 'downplayed' warning on heart-attack risk from Aids drug

The multinational drugs company GlaxoSmithKline (GSK) downplayed an early warning about the rising number of people who have suffered potentially fatal heart attacks following the use of its £600m anti-Aids drug, which is taken daily by tens of thousands of people around the world.